ScholarIQanswers from OpenAlex
AstraZeneca (Brazil)
InstitutionResearch output, impact & collaborations
AstraZeneca (Brazil) is a institution indexed in ScholarIQ from OpenAlex.
What is known about AstraZeneca (Brazil)?
ScholarIQrecord summary
AstraZeneca (Brazil) is a research organisation in São Paulo, BR. OpenAlex records 3,744 works and 1,020,034 citations for it. 1,828 researchers list it as their most recent affiliation.
How many works does AstraZeneca (Brazil) have?
ScholarIQindexed works
AstraZeneca (Brazil) has 3,744 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does AstraZeneca (Brazil) have?
ScholarIQcitation count
AstraZeneca (Brazil) has 1,020,034 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at AstraZeneca (Brazil)?
ScholarIQresearcher count
AstraZeneca (Brazil) has 1,828 researchers in the ScholarIQ index.
What is the average h-index at AstraZeneca (Brazil)?
ScholarIQavg h-index
AstraZeneca (Brazil) has an average h-index of 61.6 in OpenAlex.
What is the ROR of AstraZeneca (Brazil)?
ScholarIQror
The ROR for AstraZeneca (Brazil) is on the source record.
What is the OpenAlex record for AstraZeneca (Brazil)?
ScholarIQopenalex
The OpenAlex for AstraZeneca (Brazil) is on the source record.
Who are the most-cited researchers behind AstraZeneca (Brazil)?
ScholarIQtop researchers by citations
What are the most-cited papers on AstraZeneca (Brazil)?
ScholarIQmost cited works
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Catherine Wadsworth, Giovanni Melillo, Haiyi Jiang, Yifan Huang, Phillip A. Dennis, Mustafa Özgüroğlu
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Corinne Faivre‐Finn, Martin Reck, Johan Vansteenkiste, David R. Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, Pardeep S. Jhund, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco A. Alcocer‐Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tzvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Chiadi E. Ndumele, Janani Rangaswami, Sheryl L. Chow, Ian J. Neeland, Katherine R. Tuttle, Sadiya S. Khan, Josef Coresh, Roy O. Mathew, Carissa M. Baker‐Smith, Mercedes R. Carnethon, Jean‐Pierre Després, Jennifer E. Ho, Joshua J. Joseph, Walter N. Kernan, Amit Khera, Mikhail Kosiborod, Carolyn L. Lekavich, Eldrin F. Lewis, Kevin Bryan Lo, Bige Ozkan, Latha Palaniappan, Sonali S. Patel, Michael Pencina, Tiffany M. Powell‐Wiley, Laurence Sperling, Salim S. Virani, Jackson T. Wright, Radhika Rajgopal Singh, Mitchell S.V. Elkind
How much of the research on AstraZeneca (Brazil) is open access?
ScholarIQopen access share
100%OPEN ACCESS